Intellectus Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $674K | Hold |
2,301
| – | – | 0.14% | 170 |
|
|
2025
Q4 | $807K | Sell |
2,301
-450
| -16% | -$152K | 0.16% | 156 |
|
|
2025
Q3 | $889K | Sell |
2,751
-910
| -25% | -$283K | 0.17% | 144 |
|
|
2025
Q2 | $1.42M | Sell |
3,661
-199
| -5% | -$80K | 0.31% | 92 |
|
|
2025
Q1 | $1.68M | Sell |
3,860
-150
| -4% | -$60.2K | 0.41% | 70 |
|
|
2024
Q4 | $1.48M | Sell |
4,010
-10
| -0.2% | -$4.18K | 0.33% | 81 |
|
|
2024
Q3 | $2.09M | Sell |
4,020
-160
| -4% | -$85.5K | 0.53% | 49 |
|
|
2024
Q2 | $2.27M | Sell |
4,180
-386
| -8% | -$204K | 0.62% | 39 |
|
|
2024
Q1 | $2.37M | Buy |
4,566
+126
| +3% | +$62.7K | 0.62% | 43 |
|
|
2023
Q4 | $2.09M | Buy |
4,440
+1,171
| +36% | +$541K | 0.6% | 45 |
|
|
2023
Q3 | $1.42M | Buy |
3,269
+486
| +17% | +$220K | 0.45% | 59 |
|
|
2023
Q2 | $1.24M | Sell |
2,783
-25
| -0.9% | -$11.5K | 0.37% | 72 |
|
|
2023
Q1 | $1.29M | Buy |
2,808
+2
| +0.1% | +$952 | 0.41% | 68 |
|
|
2022
Q4 | $1.44M | Buy |
2,806
+1,051
| +60% | +$534K | 0.5% | 58 |
|
|
2022
Q3 | $797K | Buy |
1,755
+37
| +2% | +$17.7K | 0.28% | 101 |
|
|
2022
Q2 | $829K | Sell |
1,718
-314
| -15% | -$155K | 0.28% | 99 |
|
|
2022
Q1 | $998K | Sell |
2,032
-185
| -8% | -$84.6K | 0.3% | 85 |
|
|
2021
Q4 | $1.03M | Sell |
2,217
-399
| -15% | -$168K | 0.26% | 99 |
|
|
2021
Q3 | $975K | Buy |
2,616
+175
| +7% | +$66.5K | 0.24% | 115 |
|
|
2021
Q2 | $932K | Sell |
2,441
-299
| -11% | -$114K | 0.21% | 126 |
|
|
2021
Q1 | $984K | Sell |
2,740
-399
| -13% | -$128K | 0.27% | 117 |
|
|
2020
Q4 | $1.01M | Buy |
3,139
+575
| +22% | +$176K | 0.3% | 102 |
|
|
2020
Q3 | $689K | Buy |
2,564
+1,663
| +185% | +$447K | 0.26% | 112 |
|
|
2020
Q2 | $237K | Sell |
901
-356
| -28% | -$95K | 0.09% | 192 |
|
|
2020
Q1 | $285K | Buy |
+1,257
| New | +$343K | 0.14% | 167 |
|
Other funds holding ELV
VCM
VPM
